Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Reminder Systems | 1 | 2016 | 104 | 0.63 | Why? |
| Early Detection of Cancer | 2 | 2017 | 1956 | 0.35 | Why? |
| Measles virus | 2 | 2018 | 194 | 0.31 | Why? |
| Colorectal Neoplasms | 1 | 2016 | 1884 | 0.24 | Why? |
| Measles | 2 | 2018 | 608 | 0.21 | Why? |
| Italy | 15 | 2021 | 38444 | 0.16 | Why? |
| Occult Blood | 1 | 2016 | 275 | 0.13 | Why? |
| Disease Notification | 1 | 2020 | 639 | 0.13 | Why? |
| Positive-Pressure Respiration | 1 | 2020 | 1160 | 0.11 | Why? |
| Influenza, Human | 3 | 2021 | 10779 | 0.11 | Why? |
| Occupational Exposure | 2 | 2021 | 4742 | 0.11 | Why? |
| Influenza A virus | 2 | 2021 | 2234 | 0.11 | Why? |
| Communicable Diseases, Imported | 1 | 2018 | 843 | 0.10 | Why? |
| General Practitioners | 1 | 2016 | 568 | 0.10 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.09 | Why? |
| Intensive Care Units | 3 | 2020 | 29594 | 0.09 | Why? |
| Infant | 6 | 2021 | 30274 | 0.08 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.08 | Why? |
| Cough | 1 | 2021 | 4891 | 0.08 | Why? |
| Age Distribution | 3 | 2020 | 3567 | 0.08 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.08 | Why? |
| Critical Care | 2 | 2020 | 14081 | 0.08 | Why? |
| Fever | 1 | 2021 | 7795 | 0.07 | Why? |
| Contact Tracing | 2 | 2021 | 8448 | 0.06 | Why? |
| Sentinel Surveillance | 2 | 2021 | 1093 | 0.06 | Why? |
| Molecular Epidemiology | 2 | 2021 | 1638 | 0.06 | Why? |
| Seasons | 3 | 2021 | 4071 | 0.06 | Why? |
| Critical Illness | 3 | 2021 | 17281 | 0.06 | Why? |
| Patient Admission | 1 | 2019 | 5250 | 0.06 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.05 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.05 | Why? |
| Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.05 | Why? |
| Tachypnea | 1 | 2021 | 197 | 0.05 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.05 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.05 | Why? |
| Child, Preschool | 5 | 2021 | 36283 | 0.05 | Why? |
| Hospital Mortality | 2 | 2020 | 22087 | 0.05 | Why? |
| Infant, Newborn | 4 | 2021 | 23105 | 0.05 | Why? |
| Internet | 1 | 2016 | 6204 | 0.05 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.04 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.04 | Why? |
| Asia, Southeastern | 1 | 2018 | 390 | 0.04 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.04 | Why? |
| Pharyngitis | 1 | 2021 | 687 | 0.04 | Why? |
| Mass Screening | 1 | 2016 | 8005 | 0.04 | Why? |
| Chest Pain | 1 | 2021 | 578 | 0.04 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.04 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.04 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.04 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.04 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2019 | 511 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2017 | 9706 | 0.03 | Why? |
| Humans | 17 | 2021 | 930598 | 0.03 | Why? |
| Child | 5 | 2021 | 70012 | 0.03 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.03 | Why? |
| Nose | 1 | 2020 | 1093 | 0.03 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.03 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Population Surveillance | 2 | 2021 | 4967 | 0.03 | Why? |
| Adult | 8 | 2021 | 244371 | 0.03 | Why? |
| History, 21st Century | 1 | 2019 | 1849 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Female | 9 | 2021 | 380317 | 0.03 | Why? |
| Cluster Analysis | 1 | 2018 | 3001 | 0.03 | Why? |
| Male | 8 | 2021 | 367725 | 0.02 | Why? |
| Aged | 6 | 2021 | 215776 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| Laboratories | 1 | 2021 | 2858 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2021 | 3493 | 0.02 | Why? |
| Blood Donors | 1 | 2020 | 2956 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2019 | 3129 | 0.02 | Why? |
| Software | 1 | 2017 | 2501 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.02 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
| Infection Control | 2 | 2021 | 23131 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Phylogeny | 1 | 2019 | 13341 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Retrospective Studies | 2 | 2020 | 105322 | 0.01 | Why? |
| Viral Load | 1 | 2019 | 15850 | 0.01 | Why? |
| Respiratory Tract Infections | 1 | 2019 | 6817 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| RNA, Viral | 1 | 2017 | 32276 | 0.01 | Why? |
Cereda's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(99)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(136)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_